SOX4 and endometrial cancer: miR-129-2 downregulates the expression of SOX4 [74], an oncogene of the SRY-related HMGB family, and epigenetic deregulation of miR-129-2 results in overexpression of SOX4 in endometrial cancer [78] and gastric carcinoma [79].